Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
Median P/S Value
$0.00 (As of Today)

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median P/S Value is calculated as trailing twelve months (TTM) revenue per share times 10-Year median P/S ratio. Cascadian Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was $0. Cascadian Therapeutics Inc's 10-Year median P/S ratio is 240.00. Therefore, the Median P/S Value for today is $0.00.

As of today, Cascadian Therapeutics Inc's share price is $5.68. Cascadian Therapeutics Inc's median P/S value is $0.00. Therefore, Cascadian Therapeutics Inc's Price to Median P/S Value Ratio for today is 0.00.

During the past 13 years, the highest Price to Median P/S Value Ratio of Cascadian Therapeutics Inc was 20.38. The lowest was 0.00. And the median was 0.16.


Definition

Cascadian Therapeutics Inc's Median P/S Value for today is calculated as

Median P/S Value=Total Annual Sales / Shares Outstanding*10-Year Median P/S Ratio
=Revenue per Share (TTM)*10-Year Median P/S Ratio
=0*240.00
=0.00

10-Year Median P/S Ratio is 240.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cascadian Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was $0.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company’s value.

Cascadian Therapeutics Inc's Price to Median P/S Value Ratio for today is calculated as

Price to Median P/S Value=Share Price/Median P/S Value
=5.68/0.00
=

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

P/E Ratio, P/B Ratio, P/S Ratio, Intrinsic Value (DCF Projected), Intrinsic Value (DCF), Intrinsic Value (DE), Graham Number, GAVA


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
medpsvalue 258.00283.202,966.16131.760.966.960.000.000.000.00

Cascadian Therapeutics Inc Semi-Annual Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
medpsvalue 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK